chr7-134575876-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001080538.3(AKR1B15):āc.692A>Cā(p.Lys231Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
AKR1B15
NM_001080538.3 missense
NM_001080538.3 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 5.86
Genes affected
AKR1B15 (HGNC:37281): (aldo-keto reductase family 1 member B15) Enables estradiol 17-beta-dehydrogenase activity. Predicted to be involved in estrogen biosynthetic process. Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36907893).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKR1B15 | NM_001080538.3 | c.692A>C | p.Lys231Thr | missense_variant | 8/12 | ENST00000457545.7 | |
AKR1B15 | NM_001367820.1 | c.692A>C | p.Lys231Thr | missense_variant | 7/11 | ||
AKR1B15 | NM_001367821.1 | c.608A>C | p.Lys203Thr | missense_variant | 7/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKR1B15 | ENST00000457545.7 | c.692A>C | p.Lys231Thr | missense_variant | 8/12 | 5 | NM_001080538.3 | ||
AKR1B15 | ENST00000423958.2 | c.692A>C | p.Lys231Thr | missense_variant | 6/10 | 5 | |||
AKR1B15 | ENST00000652743.1 | c.608A>C | p.Lys203Thr | missense_variant | 6/10 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461558Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727078
GnomAD4 exome
AF:
AC:
2
AN:
1461558
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
727078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.692A>C (p.K231T) alteration is located in exon 8 (coding exon 6) of the AKR1B15 gene. This alteration results from a A to C substitution at nucleotide position 692, causing the lysine (K) at amino acid position 231 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Vest4
MutPred
Loss of methylation at K231 (P = 0.0029);Loss of methylation at K231 (P = 0.0029);
MVP
MPC
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.